Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Gx-IVF, Gx-TL, Gx-MOPS PLUS

K-Number: K202862 · 2021-05-14

Decision Date2021-05-14
Product CodeMQL
Advisory CommitteeOB
DecisionSubstantially Equivalent

Device Summary

Gx-IVF, Gx-TL, Gx-MOPS PLUS is a medical device manufactured by Vitrolife Sweden AB. It received FDA 510(k) clearance on 2021-05-14 under approval number K202862. The device is classified under product code MQL. It was reviewed by the OB advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Gx-IVF, Gx-TL, Gx-MOPS PLUS?

Gx-IVF, Gx-TL, Gx-MOPS PLUS is a medical device that received FDA 510(k) clearance on 2021-05-14. It is manufactured by Vitrolife Sweden AB. The 510(k) number is K202862.

When was Gx-IVF, Gx-TL, Gx-MOPS PLUS approved by the FDA?

Gx-IVF, Gx-TL, Gx-MOPS PLUS received FDA 510(k) clearance on 2021-05-14, under approval number K202862.

What company makes Gx-IVF, Gx-TL, Gx-MOPS PLUS?

Gx-IVF, Gx-TL, Gx-MOPS PLUS is manufactured by Vitrolife Sweden AB.

What is the FDA product code for Gx-IVF, Gx-TL, Gx-MOPS PLUS?

The FDA product code for Gx-IVF, Gx-TL, Gx-MOPS PLUS is MQL.

Other Devices by Vitrolife Sweden AB

View all 8 devices →

Related Devices (Code: MQL)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.